Optimizing the production of suspension cells using the G-Rex “M” series

Broader implementation of cell-based therapies has been hindered by the logistics associated with the expansion of clinically relevant cell numbers ex vivo. To overcome this limitation, Wilson Wolf Manufacturing developed the G-Rex, a cell culture flask with a gas-permeable membrane at the base that...

Full description

Bibliographic Details
Main Authors: Pradip Bajgain, Roopa Mucharla, John Wilson, Dan Welch, Usanarat Anurathapan, Bitao Liang, Xiaohua Lu, Kyle Ripple, John M Centanni, Christine Hall, David Hsu, Larry A Couture, Shubhranshu Gupta, Adrian P Gee, Helen E Heslop, Ann M Leen, Cliona M Rooney, Juan F Vera
Format: Article
Language:English
Published: Elsevier 2014-01-01
Series:Molecular Therapy: Methods & Clinical Development
Online Access:http://www.sciencedirect.com/science/article/pii/S2329050116300808
id doaj-d53190c4394a4fa6b235fead97660163
record_format Article
spelling doaj-d53190c4394a4fa6b235fead976601632020-11-24T21:30:50ZengElsevierMolecular Therapy: Methods & Clinical Development2329-05012014-01-011C10.1038/mtm.2014.15Optimizing the production of suspension cells using the G-Rex “M” seriesPradip Bajgain0Roopa Mucharla1John Wilson2Dan Welch3Usanarat Anurathapan4Bitao Liang5Xiaohua Lu6Kyle Ripple7John M Centanni8Christine Hall9David Hsu10Larry A Couture11Shubhranshu Gupta12Adrian P Gee13Helen E Heslop14Ann M Leen15Cliona M Rooney16Juan F Vera17Center for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital, Texas Children's Hospital, Houston, Texas, USACenter for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital, Texas Children's Hospital, Houston, Texas, USAWilson Wolf Manufacturing Corporation, New Brighton, Minnesota, USAWilson Wolf Manufacturing Corporation, New Brighton, Minnesota, USACenter for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital, Texas Children's Hospital, Houston, Texas, USACelgene Cellular Therapeutics, Celgene Corporation, Warren, New Jersey, USACelgene Cellular Therapeutics, Celgene Corporation, Warren, New Jersey, USAUniversity of Wisconsin–Madison, Waisman Biomanufacturing, Madison, Wisconsin, USAUniversity of Wisconsin–Madison, Waisman Biomanufacturing, Madison, Wisconsin, USACenter for Applied Technology Development, Beckman Research Institute of City of Hope, Duarte, California, USACenter for Applied Technology Development, Beckman Research Institute of City of Hope, Duarte, California, USACenter for Applied Technology Development, Beckman Research Institute of City of Hope, Duarte, California, USACenter for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital, Texas Children's Hospital, Houston, Texas, USACenter for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital, Texas Children's Hospital, Houston, Texas, USACenter for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital, Texas Children's Hospital, Houston, Texas, USACenter for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital, Texas Children's Hospital, Houston, Texas, USACenter for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital, Texas Children's Hospital, Houston, Texas, USACenter for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital, Texas Children's Hospital, Houston, Texas, USABroader implementation of cell-based therapies has been hindered by the logistics associated with the expansion of clinically relevant cell numbers ex vivo. To overcome this limitation, Wilson Wolf Manufacturing developed the G-Rex, a cell culture flask with a gas-permeable membrane at the base that supports large media volumes without compromising gas exchange. Although this culture platform has recently gained traction with the scientific community due to its superior performance when compared with traditional culture systems, the limits of this technology have yet to be explored. In this study, we investigated multiple variables including optimal seeding density and media volume, as well as maximum cell output per unit of surface area. Additionally, we have identified a novel means of estimating culture growth kinetics. All of these parameters were subsequently integrated into a novel G-Rex “M” series, which can accommodate these optimal conditions. A multicenter study confirmed that this fully optimized cell culture system can reliably produce a 100-fold cell expansion in only 10 days using 1L of medium. The G-Rex M series is linearly scalable and adaptable as a closed system, allowing an easy translation of preclinical protocols into the good manufacturing practice.http://www.sciencedirect.com/science/article/pii/S2329050116300808
collection DOAJ
language English
format Article
sources DOAJ
author Pradip Bajgain
Roopa Mucharla
John Wilson
Dan Welch
Usanarat Anurathapan
Bitao Liang
Xiaohua Lu
Kyle Ripple
John M Centanni
Christine Hall
David Hsu
Larry A Couture
Shubhranshu Gupta
Adrian P Gee
Helen E Heslop
Ann M Leen
Cliona M Rooney
Juan F Vera
spellingShingle Pradip Bajgain
Roopa Mucharla
John Wilson
Dan Welch
Usanarat Anurathapan
Bitao Liang
Xiaohua Lu
Kyle Ripple
John M Centanni
Christine Hall
David Hsu
Larry A Couture
Shubhranshu Gupta
Adrian P Gee
Helen E Heslop
Ann M Leen
Cliona M Rooney
Juan F Vera
Optimizing the production of suspension cells using the G-Rex “M” series
Molecular Therapy: Methods & Clinical Development
author_facet Pradip Bajgain
Roopa Mucharla
John Wilson
Dan Welch
Usanarat Anurathapan
Bitao Liang
Xiaohua Lu
Kyle Ripple
John M Centanni
Christine Hall
David Hsu
Larry A Couture
Shubhranshu Gupta
Adrian P Gee
Helen E Heslop
Ann M Leen
Cliona M Rooney
Juan F Vera
author_sort Pradip Bajgain
title Optimizing the production of suspension cells using the G-Rex “M” series
title_short Optimizing the production of suspension cells using the G-Rex “M” series
title_full Optimizing the production of suspension cells using the G-Rex “M” series
title_fullStr Optimizing the production of suspension cells using the G-Rex “M” series
title_full_unstemmed Optimizing the production of suspension cells using the G-Rex “M” series
title_sort optimizing the production of suspension cells using the g-rex “m” series
publisher Elsevier
series Molecular Therapy: Methods & Clinical Development
issn 2329-0501
publishDate 2014-01-01
description Broader implementation of cell-based therapies has been hindered by the logistics associated with the expansion of clinically relevant cell numbers ex vivo. To overcome this limitation, Wilson Wolf Manufacturing developed the G-Rex, a cell culture flask with a gas-permeable membrane at the base that supports large media volumes without compromising gas exchange. Although this culture platform has recently gained traction with the scientific community due to its superior performance when compared with traditional culture systems, the limits of this technology have yet to be explored. In this study, we investigated multiple variables including optimal seeding density and media volume, as well as maximum cell output per unit of surface area. Additionally, we have identified a novel means of estimating culture growth kinetics. All of these parameters were subsequently integrated into a novel G-Rex “M” series, which can accommodate these optimal conditions. A multicenter study confirmed that this fully optimized cell culture system can reliably produce a 100-fold cell expansion in only 10 days using 1L of medium. The G-Rex M series is linearly scalable and adaptable as a closed system, allowing an easy translation of preclinical protocols into the good manufacturing practice.
url http://www.sciencedirect.com/science/article/pii/S2329050116300808
work_keys_str_mv AT pradipbajgain optimizingtheproductionofsuspensioncellsusingthegrexmseries
AT roopamucharla optimizingtheproductionofsuspensioncellsusingthegrexmseries
AT johnwilson optimizingtheproductionofsuspensioncellsusingthegrexmseries
AT danwelch optimizingtheproductionofsuspensioncellsusingthegrexmseries
AT usanaratanurathapan optimizingtheproductionofsuspensioncellsusingthegrexmseries
AT bitaoliang optimizingtheproductionofsuspensioncellsusingthegrexmseries
AT xiaohualu optimizingtheproductionofsuspensioncellsusingthegrexmseries
AT kyleripple optimizingtheproductionofsuspensioncellsusingthegrexmseries
AT johnmcentanni optimizingtheproductionofsuspensioncellsusingthegrexmseries
AT christinehall optimizingtheproductionofsuspensioncellsusingthegrexmseries
AT davidhsu optimizingtheproductionofsuspensioncellsusingthegrexmseries
AT larryacouture optimizingtheproductionofsuspensioncellsusingthegrexmseries
AT shubhranshugupta optimizingtheproductionofsuspensioncellsusingthegrexmseries
AT adrianpgee optimizingtheproductionofsuspensioncellsusingthegrexmseries
AT heleneheslop optimizingtheproductionofsuspensioncellsusingthegrexmseries
AT annmleen optimizingtheproductionofsuspensioncellsusingthegrexmseries
AT clionamrooney optimizingtheproductionofsuspensioncellsusingthegrexmseries
AT juanfvera optimizingtheproductionofsuspensioncellsusingthegrexmseries
_version_ 1725961453658177536